Epiject Iv and Insulin detemir Subcutaneous
Determining the interaction of Epiject Iv and Insulin detemir Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: valproic acid
Brand name: Depakene, Depacon, Stavzor, Valproate Sodium
Synonyms: Valproic acid, Valproic Acid and Derivatives
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Epiject Iv-Insulin glargine
- Epiject Iv-Insulin Glargine (U-100) Cartridge Systems and Pens
- Epiject Iv-Insulin Glargine (U-100) Vials
- Epiject Iv-Insulin Glargine (U-300) Pens
- Epiject Iv-Insulin glargine and lixisenatide
- Epiject Iv-Insulin glargine and lixisenatide Subcutaneous
- Insulin detemir Subcutaneous-Epiklor
- Insulin detemir Subcutaneous-Epinal
- Insulin detemir Subcutaneous-Epinephrine
- Insulin detemir Subcutaneous-EPINEPHrine (Nasal)
- Insulin detemir Subcutaneous-EPINEPHrine (Oral Inhalation)
- Insulin detemir Subcutaneous-EPINEPHrine (Systemic)